Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells

Jean Ann Maguire1, Paul Gadue1,2,3, Deborah L French1,2,3

  • 1Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Current Protocols
|November 25, 2022
PubMed
Summary

This study introduces a novel CRISPR/Cas9 method using two repair templates for precise genome editing in human pluripotent stem cells, enabling efficient disease modeling and therapeutic development.